Personalized Medicine

Exploring Gene and Cell Therapy Integration in Pharmacies

January 29, 2024 - After seeing promising results in cell and gene therapy clinical trials, cell and gene therapy is transforming patient care, offering new possibilities for treating diseases that previously had limited treatment options. As pharmacies integrate these therapies into their operations, they face challenges and opportunities. In a recent conversation with Tracey James, RPh, Chief Operating...

Read More


More Articles

Optimizing Cancer Care Pathways Through Precision Medicine, RWD

by Editorial Staff

Personalized medicine is vital because it streamlines clinical decision-making through genetic tests or biomarkers. Essentially, personalized care lets caregivers feel more confident that a patient will respond to a specific drug or be...

Exploring Business Development Strategies for Pharma Startups

by Alivia Kaylor

Pharmaceutical startups face significant challenges in the ever-evolving healthcare industry. A 2020 Drug Discovery Today article emphasized that these challenges often result from unclear business models, the absence of a go-to-market...

Understanding Implications of Pharmacogenomic on Prescribing

by Veronica Salib

Pharmacogenomic research explores how specific genes or genetic variations can impact drug responses and treatment outcomes. While not a standard of care, pharmacogenomic testing can significantly impact prescribing and medication safety....

Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio

by Veronica Salib

Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio,...

How Monoclonal Antibodies Are Shaping the Future of Healthcare

by Alivia Kaylor

Monoclonal antibodies (mAbs), a groundbreaking class of therapeutic agents, have emerged as a transformative tool in modern medicine. With their remarkable precision and versatility, these engineered antibodies offer promising solutions...

Merck and Moderna Find Success with Cancer Vaccine Clinical Trial

by Hayden Schmidt

Pharmaceutical companies Merck & Co and Moderna Inc announced positive clinical trial results for their investigational melanoma vaccine candidate last week. The personalized cancer treatment that...

Disease-Modifying Antirheumatic Drugs Effectively Treat Arthritis

by Veronica Salib

Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation due to their condition. To manage...

Michigan Blue Launches Pharmacogenomics Precision Medicine Program

by Alivia Kaylor

Blue Care Network recently announced the launch of Michigan’s first end-to-end pharmacogenomics precision medicine program, Blue Cross Personalized Medicine. This program leverages genetic...

Personalized Immunotherapy Could Treat Metastatic Breast Cancer

by Samantha McGrail

Personalized immunotherapy from an individual’s tumor-fighting immune cells could potentially treat metastatic breast cancer, according to a study from the National Cancer Institute’s...

Cell and Gene Therapy Development Increased 20%, PhRMA Finds

by Samantha McGrail

There are 362 investigational cell and gene therapies currently in clinical development, a 20 percent increase from 2018, according to a recent report from Pharmaceutical Research and Manufacturers of...

Recent Articles